In a major show of institutional support, China Life Asset Management executed a single-day net purchase exceeding 10 billion yuan ($1.38 billion) in domestic equity assets. The state-backed manager reaffirmed long-term confidence in China's economy, prioritizing future allocations toward 'new quality productive forces.'

China Life Insurance has launched a 5 billion yuan ($690 million) fund focused on domestic chipmaking and semiconductor technology. The move reflects a broader policy effort to mobilize patient insurance capital to fund strategic, high-tech hardware industries.

China Securities Regulatory Commission Chairman Wu Qing held an informal symposium with individual retail investors at a local branch. The rare grassroots engagement aligns with regulators' stated commitment to foster an 'investor-oriented' capital market and address retail pain points.

China is transitioning its East-West regional assistance campaign into a permanent institutional mechanism aimed at narrowing wealth gaps between eastern and western provinces. State media highlights the shift as a crucial step toward realizing long-term 'common prosperity' goals.

China's major 'big science' facility, the High-Intensity Heavy-Ion Accelerator, has officially entered trial operation. The facility will significantly enhance domestic capabilities in basic nuclear physics research and interdisciplinary science.